Skip to main content

Wegovy weight-loss drug supply to be temporarily curtailed by Novo Nordisk as it ramps up production

Novo Nordisk on Thursday said demand is so strong for its weight loss injectable medicine that it will have to reduce the supply temporarily.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.